QEL-005
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Quell Therapeutics Limited
Overview
QEL-005 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
QEL-005 clinical trials
Explore related
Medical disclaimer. This page summarizes research about QEL-005 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.